MD Anderson Cancer Center has selected Oracle Corporation's Health Sciences applications and Oracle technology as the foundation for an organization-wide analytics initiative designed to enable a new generation of personalized cancer treatment that improves outcomes. The platform will also support the center's renowned Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Oracle applications and technology will power the enterprise analytics initiative, one of the program's platforms. The new platform will bring together clinical, genomic, financial, administrative and operational information from internal and external sources to yield insights that drive care innovation and optimize operational efficiency.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
142.6 USD | -0.32% | +1.37% | +35.27% |
16/07 | Coveo Appoints John Grosshans as Chief Revenue Officer | CI |
15/07 | Hedge funds' bets on software companies hit record lows, Morgan Stanley says | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.27% | 39TCr | |
+34.23% | 24TCr | |
+7.69% | 16TCr | |
+27.86% | 6.5TCr | |
+38.72% | 3.93TCr | |
+163.50% | 2.86TCr | |
-15.80% | 2.4TCr | |
+32.29% | 2.19TCr | |
+49.51% | 1.44TCr | |
+10.17% | 1.4TCr |
- Stock Market
- Equities
- ORCL Stock
- News Oracle Corporation
- The University of Texas MD Anderson Cancer Center Selects Oracle Corporation's Applications and Technology as Part of Platform to Help Transform Cancer Care